Thursday
Oct042012
Stellar Biotechnologies Announces Filing US Letters Patent Application
Date: October 4, 2012
SOURCE: Stellar Biotechnologies, Inc.
Find other news re. KLH Business Development, KLH as Diagnostic Antigen
KLH in News
News of companies, products and development related to KLH. Full information is provided by link to third-party sites.
(in order by date)
Friday
Sep282012
IEEE New Medicine Series: Harvesting Blood from Limpets for a Cancer Vaccine
Date: September 28, 2012
SOURCE: IEEE Spectrum series “The New Medicine"
Find other news re. Environmental, KLH Aquaculture
Wednesday
Sep262012
Stellar Biotechnologies Presented at World Congress of Marine Biotechnology
Date: September 26, 2012
SOURCE: Stellar Biotechnologies, Inc.
Find other news re. Environmental, KLH Business Development
Thursday
Sep202012
Biovest Conducts Meeting with EMA Advancing Process to Seek EU Approval for Cancer Vaccine
Date: September 20, 2012
SOURCE: Biovest International, Inc.
Find other news re. KLH in Therapeutic Vaccines
Tuesday
Aug142012
Biovest Conducts End of Phase III Review with FDA of BiovaxID™ as Consolidation Therapy in Non-Hodgkin’s Lymphoma
Date: August 14, 2012
SOURCE: Biovest International, Inc.
Find other news re. KLH in Therapeutic Vaccines
Thursday
Jul122012
Biovest’s Eligibility to Seek EU Marketing Approval for its BiovaxID Cancer Vaccine as Orphan Drug Confirmed by EMA
Date: July 12, 2012
SOURCE: Biovest International, Inc.
Find other news re. KLH in Therapeutic Vaccines
Friday
Jul062012
Drug Addiction Vaccine
Date: July 6, 2012
SOURCE: NewsChannel5.com (Nashville, TN) (Ivanhoe Newswire)
Find other news re. KLH in Therapeutic Vaccines
Monday
Jun252012
Stellar Biotechnologies to Present at ImVacS 2012 Summit on August 13 - 16, 2012
Date: June 25, 2012
SOURCE: Stellar Biotechnologies, Inc.
Find other news re. KLH Business Development
Wednesday
Jun202012
Stellar Biotechnologies to Present at ICAAC 2012 Conference on September 9 - 12, 2012
Date: June 20, 2012
SOURCE: Stellar Biotechnologies, Inc.
Find other news re. KLH in Therapeutic Vaccines
Thursday
Jun072012
NCI Study Demonstrates Significant Overall Survival and Time-to-Next-Treatment Benefits for BiovaxID® Cancer Vaccine Following Rituximab-Chemotherapy in Mantle Cell Lymphoma Study
Date: June 7, 2012
SOURCE: Biovest International, Inc.
Find other news re. KLH in Therapeutic Vaccines